Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02087800 · ClinicalTrials.gov registry record
Smoking, Stress & Allopregnanolone Response
A clinical trial of Smoking Cessation, sponsored by University of Minnesota.
- Completed
- Registry status
- 43
- Enrollment target
- 1
- Study location
NCT02087800 is a study of Smoking Cessation that has completed, run by University of Minnesota. The registered enrollment target is 43 participants, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02087800, a study of Smoking Cessation, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 43 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to characterize the effect of smoking on stress-induced allopregnanolone (ALLO) response in women by menstrual phase. The investigators hypothesize that women who smoke will have a blunted ALLO response to stress.
Conditions Studied
Interventions
- BEHAVIORAL F phase lab session
- BEHAVIORAL L phase lab session
Study Locations (1)
Minnesota
- University of Minnesota Tobacco Research Program - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2014-04 |
| Est. Completion | 2015-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02087800
The ClinicalTrials.gov registry entry for NCT02087800 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (91% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 2 interventions - of which F phase lab session is the first listed.
NCT02087800 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT02087800 about?
NCT02087800 is a clinical study titled "Smoking, Stress & Allopregnanolone Response". This study aims to characterize the effect of smoking on stress-induced allopregnanolone (ALLO) response in women by menstrual phase. The investigators hypothesize that women who smoke will have a blunted ALLO response to stress.
What is the current status of trial NCT02087800?
This trial is currently completed. The enrollment target is 43 participants. The study started on 2014-04. Estimated completion is 2015-08.
What conditions does trial NCT02087800 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT02087800?
The interventions under investigation include: F phase lab session (BEHAVIORAL), L phase lab session (BEHAVIORAL).
Who is sponsoring clinical trial NCT02087800?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02087800 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
RECRUITING
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
RECRUITING · Phase 4
-
Examining the Effects of Cytisinicline on Neural Substrates of Cigarette Cue-reactivity
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.